InvestorsObserver is giving Bausch Health Companies Inc (BHC) an Analyst Rating Rank of 18, meaning BHC is ranked higher by analysts than 18% of stocks. The average price target for BHC is $11.25 and analyst’s rate the stock as a Buy.
Why are Analyst Ratings Important?
Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected.
InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.
What’s Happening With Bausch Health Companies Inc Stock Today?
Bausch Health Companies Inc (BHC) stock is trading at $7.68 as of 10:57 AM on Thursday, Dec 15, a loss of -$0.18, or -2.29% from the previous closing price of $7.86. The stock has traded between $7.64 and $7.79 so far today. Volume today is less active than usual. So far 1,102,210 shares have traded compared to average volume of 5,512,900 shares.
Click Here to get the full Stock Report for Bausch Health Companies Inc stock.
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You’re all set to receive the Morning Update newsletter
Read More: Do Analysts Think You Should Hold?